Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasper Dingemanse

Showing results (1-10 of 246) with videos related to

Pageof 25
Sort By:
Cardiovascular Therapeutics|February 28, 2014
Reply to letter: Age and sex effects on the single- and multiple-dose safety and pharmacokinetics of the new renin inhibitor ACT-178882Jasper Dingemanse
Idrugs : the Investigational Drugs Journal|October 31, 2007
World Federation of Sleep Research and Sleep Medicine Societies (worldsleep07)--5th Congress. 2-6 September 2007, Cairns, QLD, AustraliaJasper Dingemanse
Current Opinion in Investigational Drugs (London, England : 2000)|November 19, 2003
Nemifitide. InnapharmaJasper Dingemanse
Clinical Drug Investigation|February 6, 2013
Drug-drug interaction study of ACT-178882, a new renin inhibitor, and diltiazem in healthy subjectsJasper Dingemanse, Laurent Nicolas
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 25, 2017
Impact of pharmacokinetic-pharmacodynamic modelling in early clinical drug developmentJasper Dingemanse, Andreas Krause
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 22, 2015
Authors' reply to Srinivas: "pharmacokinetics and tolerability of the novel oral prostacyclin IP receptor agonist selexipag"Priska Kaufmann, Jasper Dingemanse
Cardiovascular Therapeutics|January 15, 2013
Age and sex effects on the single- and multiple-dose safety and pharmacokinetics of the new renin inhibitor ACT-178882Jasper Dingemanse, Laurent Nicolas
Drugs in R&D|June 6, 2013
Absence of pharmacokinetic and pharmacodynamic interactions between almorexant and warfarin in healthy subjectsJasper Dingemanse, Petra Hoever
European Journal of Drug Metabolism and Pharmacokinetics|November 28, 2019
Effect of Multiple-Dose Aprocitentan Administration on the Pharmacokinetics of Midazolam in Healthy Male SubjectsPatricia N Sidharta, Jasper Dingemanse
Clinical Pharmacology in Drug Development|June 28, 2020
Effects of Multiple-Dose Administration of Aprocitentan on the Pharmacokinetics of RosuvastatinPatricia N Sidharta, Jasper Dingemanse
Pageof 25

Showing results (1-10 of 246) with videos related to

Sort By:
Pageof 25
Cardiovascular Therapeutics|February 28, 2014
Reply to letter: Age and sex effects on the single- and multiple-dose safety and pharmacokinetics of the new renin inhibitor ACT-178882Jasper Dingemanse
Idrugs : the Investigational Drugs Journal|October 31, 2007
World Federation of Sleep Research and Sleep Medicine Societies (worldsleep07)--5th Congress. 2-6 September 2007, Cairns, QLD, AustraliaJasper Dingemanse
Current Opinion in Investigational Drugs (London, England : 2000)|November 19, 2003
Nemifitide. InnapharmaJasper Dingemanse
Clinical Drug Investigation|February 6, 2013
Drug-drug interaction study of ACT-178882, a new renin inhibitor, and diltiazem in healthy subjectsJasper Dingemanse, Laurent Nicolas
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 25, 2017
Impact of pharmacokinetic-pharmacodynamic modelling in early clinical drug developmentJasper Dingemanse, Andreas Krause
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 22, 2015
Authors' reply to Srinivas: "pharmacokinetics and tolerability of the novel oral prostacyclin IP receptor agonist selexipag"Priska Kaufmann, Jasper Dingemanse
Cardiovascular Therapeutics|January 15, 2013
Age and sex effects on the single- and multiple-dose safety and pharmacokinetics of the new renin inhibitor ACT-178882Jasper Dingemanse, Laurent Nicolas
Drugs in R&D|June 6, 2013
Absence of pharmacokinetic and pharmacodynamic interactions between almorexant and warfarin in healthy subjectsJasper Dingemanse, Petra Hoever
European Journal of Drug Metabolism and Pharmacokinetics|November 28, 2019
Effect of Multiple-Dose Aprocitentan Administration on the Pharmacokinetics of Midazolam in Healthy Male SubjectsPatricia N Sidharta, Jasper Dingemanse
Clinical Pharmacology in Drug Development|June 28, 2020
Effects of Multiple-Dose Administration of Aprocitentan on the Pharmacokinetics of RosuvastatinPatricia N Sidharta, Jasper Dingemanse
Pageof 25